Avenue at Lyndhurst: Anxiety Med Missed 3 Days - OH
Resident 99 was prescribed Alprazolam 0.5 mg, one tablet by mouth at bedtime for anxiety. The medication wasn't given on February 14, 15, or 17, according to federal inspection records from an August complaint investigation.
For February 14, nursing staff left no notes explaining why the dose was missed.
The first documentation appeared at 2:17 a.m. on February 15, when a nurse noted the Alprazolam was "pending delivery." But the note contained no indication that anyone had contacted the pharmacy or provider to resolve the delay.
No action was taken for nearly 19 hours.
At 8:51 p.m. on February 15, a nurse finally documented contacting the resident's provider about the missing prescription. The note revealed the provider had to give the nurse his personal cell phone number for the pharmacy to call directly. The nurse called the pharmacy as instructed and provided the provider's number, but the medication remained pending.
By February 17, the resident still hadn't received the anxiety medication. Nursing notes for that day contained no mention of the continued delay or any efforts to resolve it.
When federal inspectors interviewed the facility's Director of Clinical Services on August 22, she verified that no nursing notes existed for February 14 or February 17 regarding the missing Alprazolam. She acknowledged that no action was taken until late on February 15, creating a significant delay in the resident receiving prescribed anxiety medication.
The inspection was triggered by two separate complaints filed with state health officials.
Alprazolam is a controlled substance commonly prescribed for anxiety disorders. Abrupt discontinuation can cause withdrawal symptoms including increased anxiety, restlessness, and in severe cases, seizures. Federal nursing home regulations require facilities to ensure residents receive medications as prescribed by their physicians.
The facility's medication management failures extended beyond simple documentation gaps. Staff had multiple opportunities over 72 hours to identify and address the missing prescription but failed to act until the second day, and even then only documented minimal efforts.
The February 15 nursing note revealed systemic communication problems. The provider had to give his personal cell phone number directly to the pharmacy, suggesting the facility's normal medication ordering processes had broken down entirely.
After the provider's direct intervention, the medication still remained unavailable, indicating either pharmacy delays or continued facility management issues.
The resident experienced this medication gap during what appeared to be a transition period when prescriptions required renewal or reordering. However, federal regulations require nursing homes to maintain adequate medication supplies and have procedures for preventing interruptions in prescribed treatments.
The facility's response to the missing medication showed a reactive rather than proactive approach to resident care. Instead of immediately identifying why the February 14 dose was missed and taking steps to prevent further delays, staff allowed the situation to continue for three days.
Documentation failures compounded the medication management problems. Proper nursing notes would have created a paper trail showing when the issue was identified, what steps were taken, and who was responsible for resolution. The absence of notes on February 14 and 17 left gaps in the resident's medical record during a period when they were missing prescribed medication.
The inspection found the facility's actions represented minimal harm or potential for actual harm to residents. However, the three-day delay in anxiety medication could have caused significant distress for someone depending on the prescription for symptom management.
Federal inspectors classified this as affecting "few" residents, suggesting the medication management problems weren't widespread throughout the facility. However, the case revealed concerning gaps in the facility's systems for tracking and ensuring medication availability.
The facility must now develop and implement corrective measures to prevent similar medication delays. This typically includes reviewing medication ordering procedures, staff training on documentation requirements, and establishing backup systems for when prescriptions aren't available as scheduled.
Resident 99's experience illustrates how administrative failures can directly impact patient care, leaving vulnerable residents without prescribed treatments while staff struggle to navigate basic medication management processes.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Avenue At Lyndhurst from 2025-08-28 including all violations, facility responses, and corrective action plans.
Additional Resources
Data source: Official federal inspection data from the Centers for Medicare & Medicaid Services (CMS).
Editorial process: AI-synthesized regulatory data, reviewed for accuracy by our editorial team.
Professional review: All content reviewed by Christopher F. Nesbitt, Sr., NH EMT & BU-trained Paralegal.
Last verified: June 20, 2026 · Our methodology
AVENUE AT LYNDHURST in LYNDHURST, OH was cited for violations during a health inspection on August 28, 2025.
Resident 99 was prescribed Alprazolam 0.5 mg, one tablet by mouth at bedtime for anxiety.
Health inspections identify deficiencies that facilities must correct. Violations range from minor documentation issues to serious safety concerns. Review the full report below for specific details and facility response.